China expert consensus on clinical application of the drug-coated balloon

China expert consensus on clinical application of the drug-coated balloon

Percutaneous coronary intervention (PCI) has become the mainstay in the treatment of coronary heart disease (CHD). In the past 10 years, the number of PCI procedures for CHD has maintained an annual growth of 15%–20% on average in China. As a consequence, in-stent restenosis (ISR) has become an incr...

Full description

Bibliographic Details
Main Authors: Yundai Chen, Jianan Wang, Bin Liu, Fusui Ji, Chunguang Qiu, Shubin Qiao, Jiyan Chen, Xianghua Fu, Chuanyu Gao, Bao li, Zhanquan Li, Yong Huo, Junbo Ge
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2016-01-01
Series:Cardiology Plus
Subjects:
Bifurcation lesions
coronary artery diseases
de novo coronary lesions
drug-coated balloon
in-stent restenosis
small vessel lesions
Online Access:http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2016;volume=1;issue=2;spage=38;epage=44;aulast=Chen

Internet

http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2016;volume=1;issue=2;spage=38;epage=44;aulast=Chen

Similar Items